Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 13HIV Infections 8Acquired Immunodeficiency Syndrome 8Testicular Neoplasms 6Hodgkin Disease 6Teratoma 5Lymphoma, Non-Hodgkin 5Testicular Germ Cell Tumor 4Sarcoma, Kaposi 4Lymphoma, Large B-Cell, Diffuse 3Endodermal Sinus Tumor 3Carcinoma, Embryonal 3Seminoma 2Recurrence 2Ovarian Neoplasms 2Ovarian Germ Cell Cancer 2Lymphoma, Large-Cell, Immunoblastic 2Teratoma, Testicular 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nervous System Neoplasms 1Melanoma 1Lymphoma, Follicular 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Head and Neck Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1AIDS-Related Complex 1

Interventions

sargramostim 1Vincristine 1Methotrexate 1Leucovorin 1Doxorubicin 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Nervous System Neoplasms × Bleomycin × Clear all
NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡